• Arab drug company for pharmaceuticals was established in 1963, It is an Egyptian joint venture company having  a long history of achievements since its foundation as it is considered as one of the leading companies in pharmaceutical drug manufacturing in Egypt and the Arab world.

Adco Co. has a unique competitive advantage for being the first producer and a specialized pioneer for the production of inhalers and sprays in Egypt and the Middle East.

The aerosoles manufacturing line was primarily founded in early nineties and was using Freon gas as a carrying base in its production, but in year 2006, Egypt had  signed on “Montréal  agreement” for fighting environmental damage caused by Freon , since that commitment, the company has worked hard to exchange this gas to another environmentally  friend one, and assigned all the items stated in this agreement, by a  successful collaboration with UNIDO association that aided the company with technology transfer supported by international experts assigned from Cardiff  University in England and the Italian company “Ferry” with the Advisory consultation Group 12 C.

The company is developing another new section for the production of “Metered Dose Inhalers” in accordance to the latest GMP guidelines and the national requirements of the Egyptian Ministry of Health , it was successfully approved and licensed and began its actual production lately in December 2010 beside its old production of traditional inhalers used internally by inhalation or externally as topical anesthetic sprays or topical antibiotic spray “Polybiotic Spray”, which is used widely for patients with burns and for surgical wounds.

The company is planning to double its production from inhalers and sprays by establishing another production line to cover all the Egyptian market and export demands, this planning will be carried out totally and side by side with the renovation and modernization of other production lines such as tablets, capsules, ointments, creams, suppositories and syrups.

website

www.adcopharma.com

Proudcts company catalog

download

Proudcts company profile

download

 

 

 

Members of the Board

Dr/ Osama  Abdel Baset                                  Managing Director

 Dr/ Mahmoud  abbas hamdy                           Chairman Of The Board

Mr/ Ahmed hamdy abbas                                Non-Executive Member

 Mr/ Mohamed hamida yones breek               Elected Member 

Mr/Maher mqar touadrous                                  Elected Member

 Audit Committee:

DrMahmoud abbas hamdy                           Director 

MrAmed hamdy abbas elawadi                   Member

Mr/Maher mqar touadrous                                 Member

Mr/Mohamed khaled salah abd elsalam              Member

Indicator 2017-2018 2018-2019 2019-2020
Net Operating Revenue 382929 43647 521073
Interest Expenses 871 660 0
Net Income 39466 43103 92800
Net Equity 146235 189504 248786
Working Capital 87802 137128 201356
Total Investment 274689 298590 371834
Salaries 89043 93899 99600
Number of workers 1295 1261 1192